Related references
Note: Only part of the references are listed.CIP2A Is a Predictor of Poor Prognosis in Colon Cancer
Hao-Wei Teng et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2012)
CIP2A is overexpressed in esophageal squamous cell carcinoma
Wei Qu et al.
MEDICAL ONCOLOGY (2012)
CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis
Peng Xu et al.
MEDICAL ONCOLOGY (2012)
CIP2A is Overexpressed in Non-Small Cell Lung Cancer and Correlates with Poor Prognosis
Qian-Ze Dong et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression
Claire M. Lucas et al.
BLOOD (2011)
Prognostic role of CIP2A expression in serous ovarian cancer
C. Bockelman et al.
BRITISH JOURNAL OF CANCER (2011)
Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival
J. Ren et al.
BRITISH JOURNAL OF CANCER (2011)
High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer
C. Bockelman et al.
BRITISH JOURNAL OF CANCER (2011)
7th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction
Thomas W. Rice et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
CIP2A expression and localization in oral carcinoma and dysplasia
Joseph Katz et al.
CANCER BIOLOGY & THERAPY (2010)
CIP2A expression is increased in prostate cancer
Markku H. Vaarala et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
CIP2A Is Associated with Human Breast Cancer Aggressivity
Christophe Come et al.
CLINICAL CANCER RESEARCH (2009)
MYC-Dependent Regulation and Prognostic Role of CIP2A in Gastric Cancer
Anchit Khanna et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells
Wenjuan Li et al.
CLINICAL CANCER RESEARCH (2008)
CIP2A inhibits PP2A in human malignancies
Melissa R. Junttila et al.
CELL (2007)
c-Myc overexpression is strongly associated with metaplasia-dysplasia-adenocarcinoma sequence in the esophagus
M. K. Schmidt et al.
DISEASES OF THE ESOPHAGUS (2007)
Protein phosphatase 2A regulatory subunit b56α associates with c-Myc and negatively regulates c-Myc accumulation
HK Arnold et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro
C Tselepis et al.
GUT (2003)
Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery
WM Ye et al.
GASTROENTEROLOGY (2001)
Frequent c-myc amplification in high-grade dysplasia and adenocarcinoma in Barrett esophagus
M Sarbia et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2001)
Share Paper
